About
MediVIE Tech develops PULSAR, a medical-grade wearable solution for continuous vital-sign monitoring.
PULSAR is designed to help healthcare teams detect clinical deterioration earlier by continuously monitoring key physiological parameters such as heart rate, oxygen saturation, respiratory rate and blood pressure trends, and by turning these signals into actionable insights for clinicians.
Our ambition is to address one of the major blind spots in healthcare: the lack of continuous monitoring for patients outside intensive care units, including standard hospital wards, post-operative care, cardiology, pneumology, home hospitalization and remote patient monitoring.
MediVIE Tech combines proprietary hardware, embedded software, signal processing algorithms and an intuitive clinical interface to provide reliable, continuous and workflow-compatible patient monitoring.
We are currently developing clinical partnerships with hospitals and healthcare groups, while advancing our regulatory and quality roadmap under the EU Medical Device Regulation, with a Class IIa positioning.
At VivaTech 2026, we are looking to connect with hospitals, healthcare providers, strategic partners, investors, medtech and digital health stakeholders, and potential industrial or commercial partners interested in the future of continuous patient monitoring.
Additional Information
Booth number at VivaTech 2026
CCI Ile de France